15 WiSys Technologies in "Miscellaneous" or "Information Technology" or "Pharmaceuticals & Vitamin D"
WiSys is currently seeking strategic partners in the golf training aid and accessories market that are interested in further developing this golf swing improvement tool for production-scale manufacturing, ultimately providing a path to market for commercialization.
WiSys is currently seeking strategic partners in the next generation transistor industry that are interested in further optimizing the design for large-scale manufacturing, ultimately providing a path to market for its commercialization.
WiSys is seeking strategic partners for further development of its controlled liquid dosing technology including optimization of the design for efficiency and manufacturing, followed by marketing, sales, and distribution.
WiSys is seeking a strategic partner for further optimization of the design for efficiency and manufacturing, followed by marketing, sales, and distribution.
Improved wheelchair design utilizing linear rotary motion with enhanced efficiency and reduced injury and pain for users
WiSys is seeking a strategic partner in the Durable Medical Equipment industry interested in gaining a competitive edge in the marketplace. WiSys' new and improved wheelchair design is the first application developed using the patented linear rotary motion platform technology and is available for exclusive licensing. Additional fields of use are available for development and licensing.
WiSys Technology Foundation is seeking a commercial partner who is interested in licensing and distributing an educational app focused on Physics, expanding the platform beyond Android applications as well as further developing additional apps directed towards other STEM disciplines.
WiSys Technology Foundation is seeking a strategic partner for manufacturing, marketing, sales, and distribution of a lift that allows para-equestrian riders to independently saddle their horses.
WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.